New-age Japanese Encephalitis vaccine
A new age single dose vaccine with over 90% protection
rate against Japanese Encephalitis (JE), which kills thousands of Indian children every year, will soon be
available in the country. ]
The vaccine Imojev, made by French pharma giant Sanofi Pasteur, can be used for immunization of those 12 months and older and has undergone successful multi-centre studies in the US, Australia, Thailand and the Philippines with more than 2,400 adults and 2,200 children receiving the vaccine.
The vaccine Imojev, made by French pharma giant Sanofi Pasteur, can be used for immunization of those 12 months and older and has undergone successful multi-centre studies in the US, Australia, Thailand and the Philippines with more than 2,400 adults and 2,200 children receiving the vaccine.
A pivotal Phase III study in adults showed that a single
dose of Imojev is as good as three doses of other vaccines available.
JE, a mosquito-borne virus, affects the central nervous system.
The JE virus is transmitted to humans via the bite of an infected mosquito. The mosquitoes usually get infected when feeding on domestic pigs carrying the virus.
JE, a mosquito-borne virus, affects the central nervous system.
The JE virus is transmitted to humans via the bite of an infected mosquito. The mosquitoes usually get infected when feeding on domestic pigs carrying the virus.
No comments:
Post a Comment